TAYLOR TOPE: Open Payments
NPI 1972955185 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 73 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,406 · 2025 $1,164
Food & beverage: $1,164
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $467 |
| Otsuka America Pharmaceutical, Inc. | 9 | $145 |
| Alkermes, Inc. | 6 | $125 |
| Corium, LLC | 5 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Vanda Pharmaceuticals Inc. | 2 | $73 |
| Collegium Pharmaceutical, Inc. | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Bausch Health US, LLC | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: VRAYLAR, REXULTI, ARISTADA, Azstarys, COBENFY, FANAPT, Jornay PM, AUSTEDO XR.
Industry payments across OK — which companies pay providers there.
